Glucose Lowering Medications in Type 2 Diabetes
|Earn up to 1.0 Mainpro+ credit* in about 30 minutes, held in your office at a time that is convenient for you.|
During the academic detailing session, participants will have the opportunity to discuss:
- What the evidence says about the efficacy and safety of non insulin glucose lowering medications in terms of their effect on diabetes related morbidity and mortality.
- What the evidence says about how an intensive glucose lowering strategy compares to a less intensive strategy.
- What impact increasing the dose of non insulin glucose lowering medications has on hemoglobin A1C (A1C).
- What are important contraindications, precautions, adverse events and drug interactions to be aware of when prescribing and/or monitoring patients on non insulin glucose lowering medications.
|When:||Until September 2017|
|Where:||Your office at your convenience, or via individual Web session|
|How:||Email firstname.lastname@example.org or Phone 604 660-2101|
For more information about the PAD service, see PAD Frequently Asked Questions.
* The University of British Columbia Division of Continuing Professional Development (UBC CPD) is fully accredited by the Committee on Accreditation of Continuing Medical Education (CACME) to provide study credits for continuing medical education for physicians. This course has been reviewed and approved by the UBC Division of Continuing Professional Development. This Group Learning course meets the certification criteria of the College of Family Physicians of Canada and has been certified by UBC CPD for up to 1.0 Mainpro+ credits. Each physician should claim only those credits he/she actually spent in the activity.